Deuterated benzopyran compounds and the use in the treatment of pain and inflammation
US9770432B2 · kind B2 · utility
0Cited by
8References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2016 |
| Grant date | Sep 26, 2017 |
| Priority date | — |
| Expiry date | Jun 14, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses deuterated benzopyran compounds having structure features as shown in Formula (I), or pharmaceutically acceptable salts or stereoisomers thereof, or prodrug molecules thereof. With excellent anti-inflammatory and analgesic effects and the capability to inhibit growth of tumor cells, such compounds are novel COX-2 selective inhibitors. The compounds and pharmaceutically acceptable salts thereof disclosed by the present application can be applied in preparing anti-inflammatory and analgesic drugs and drugs for treating or preventing tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.